The need for global access to biomedical innovations during pandemics
- 24 May 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 39 (6), 664-666
- https://doi.org/10.1038/s41587-021-00942-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantThe New England Journal of Medicine, 2021
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantThe New England Journal of Medicine, 2021
- Variant-proof vaccines — invest now for the next pandemicNature, 2021
- International collaboration and covid-19: what are we doing and where are we going?BMJ, 2021
- The lightning-fast quest for COVID vaccines — and what it means for other diseasesNature, 2020
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysisBMJ, 2020
- Advancing new tools for infectious diseasesScience, 2020
- Disease X: accelerating the development of medical countermeasures for the next pandemicThe Lancet Infectious Diseases, 2020
- Negotiating Equitable Access to Influenza Vaccines: Global Health Diplomacy and the Controversies Surrounding Avian Influenza H5N1 and Pandemic Influenza H1N1PLoS Medicine, 2010